These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 239806)

  • 21. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Andrén L; Sivertsson R; Hansson L
    Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic and physiologic considerations of adrenoceptor blockade.
    Frohlich ED; Dunn FG; Messerli FH
    Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension.
    Simon G; Kiowski W; Julius S
    Clin Pharmacol Ther; 1977 Sep; 22(3):293-8. PubMed ID: 330077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenoceptor-blocking agents in the management of hypertension.
    Prichard BN
    Cardiology; 1979; 64 Suppl 1():44-87. PubMed ID: 42488
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for beta-adrenoceptor blocking drugs in hypertension.
    Lorimer AR; Jones JV; Clark B; Dunn FG; Melville D; Lawrie TD
    Postgrad Med J; 1976; 52 Suppl 4():81-5. PubMed ID: 9635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of systemic autonomic inhibition on the hemodynamic response to antihypertensive therapy with timolol.
    Simon G; Kiowski W; Julius S
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):507-10. PubMed ID: 528098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short- and long-term therapy of mild essential hypertension with timolol.
    Harris FJ; Tonkin M; Pratt C; DeMaria AN; Amsterdam EA; Mason DT
    Clin Pharmacol Ther; 1981 Dec; 30(6):765-72. PubMed ID: 7030579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic mechanisms in human hypertension and in spontaneously hypertensive rats.
    Frohlich ED; Pfeffer MA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():225s-238s. PubMed ID: 1077770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience with timolol maleate monotherapy of hypertension.
    Bannon JA; Stewart KA; DeLisser O; Schrogie JJ
    Arch Intern Med; 1986 Apr; 146(4):654-7. PubMed ID: 3963944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
    Prichard BN
    Br J Clin Pharmacol; 1978 May; 5(5):379-99. PubMed ID: 26370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta adrenergic blocking drugs. Present position and future development.
    Fitzgerald JD
    Acta Cardiol; 1972; ():Suppl 15:199-2. PubMed ID: 4147608
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemodynamic changes in patients with coronary heart disease after beta-adrenergic blockade with propranolol.
    Bürgin D
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):365-70. PubMed ID: 4395489
    [No Abstract]   [Full Text] [Related]  

  • 37. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta blockers in hypertension.
    Thadani U
    Am J Cardiol; 1983 Nov; 52(9):10D-15D. PubMed ID: 6139008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.